Scientists test combo attack to boost immune system against pancreatic cancer
Disease control
Completed
This study tested whether adding one or two experimental immunotherapy drugs to standard chemotherapy, given both before and after surgery, could better control high-risk pancreatic cancer. It involved 28 adults with surgically removable pancreatic cancer who had not received pri…
Phase: PHASE2 • Sponsor: Lei Zheng • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC